GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Trans-Pacific Strategic Economic Partnership Agreement (TPP); provisions related to intellectual property, market access and public health issues Transatlantic Trade and Investment Partnership (TTIP); provisions related to market access intellectual property, regulatory harmonization and other issuesIndia innovation, IP and market access issues International market access and intellectual property issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHIRA KILCOYNE | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
Taxation/Internal Revenue Code TAX
H.R. 6727, U.S. Job Creation and Manufacturing Competitiveness Act of 2013; provisions related to the emporary duty suspension for preparations, such as tablets or chewing gum, intended to assist smokers to stop smoking Tax reform policy issues; provisions related to corporate tax reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY HEIMBERG | — |
| JOSEPH MCGOWAN | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Copyright/Patent/Trademark CPT
H.R. 2582, PATENT Jobs Act; provisions related to patent user fees H.R. 2766, STOP Act; provisions related to business method patents S. 214, The Preserve Access to Affordable Generics Act; provisions relating to patent settlements S. 504, Fair and Immediate Release of Generic Drugs Act; provisions related to patent settlementsS. 866, Patent Quality Improvement Act of 2013; Business methods patents provisions Biopharmaceutical innovation policy issues Biologics data protection issues Counterfeit drug issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY HEIMBERG | — |
| JOSEPH MCGOWAN | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Health Issues HCR
H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; provisions related to supply chain security H.R. 3204, Drug Quality and Security Act; provisions relating to pharmacy compounding and supply chain H.R. 6584, Verifying Authority and Legality in Drug Compounding Act; provisions relating to drug compounding S. 957, Drug Supply Chain Security Act, provisions related to supply chain securityS. 959, Pharmaceutical Compounding Quality and Accountability Act; provisions related to pharmaceutical compounding S. 1165, Access to Appropriate Immunizations for Veterans Act of 2013; provisions related to extending VA performance measure to include all federally recommended vaccine S. 610, Family Health Care Flexibility Act; provisions relating to reimbursement of OTC drugs under flexible spending and health savings accounts H.R. 1248, Family Health Care Flexibility Act; provisions relating to reimbursement of OTC drugs under flexible spending and health savings accounts Implementation issues relating to the Patient Protection and Affordable Care Act (PPACA) (Public Law 111-148), including Standards Related to Essential Health Benefits, Actuarial Value, and Accreditation rulemaking FDA special medical use; issues related to limited population antibacterial drug approval pathway FDA accelerated approval policy issues Comparative effectiveness policy issues Biopharmaceutical innovation policy issues Pharmaceutical supply chain security issues 340B policy issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY HEIMBERG | — |
| JOSEPH MCGOWAN | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Medicare/Medicaid MMM
H.R. 351, Protecting Seniors' Access to Medicare Act of 2013; provisions related to the Independent Payment Advisory Board H.R. 928, Medicare Prescription Drug Savings and Choice Act of 2013; provisions related to Medicare Part D H.R. 1024, Medication Therapy Empowerment Act of 2013; provisions related to Part D issues H.R. 1588, Medicare Drug Savings Act of 2013; provisions related to Part D issuesH.R. 2810, Medicare Patient Access and Quality Improvement Act of 2013 S. 117, Medicare Prescription Drug Price Negotiation Act of 2013; provisions related to Part D issues S. 351, Protecting Seniors' Access to Medicare Act of 2013; provisions related to the Independent Payment Advisory Board S. 408, Medicare Prescription Drug Savings and Choice Act of 2013; provisions related to Medicare Part D S. 557, Medication Therapy Empowerment Act of 2013; provisions related to Part D issues S. 740, Medicare Drug Savings Act of 2013; provisions related to Part D issues Dual eligibles coordination policy issues Deficit reduction policy issues Medicaid Program, Covered Outpatient Drugs rulemaking Implementation Issues relating to the Physician Payment Sunshine Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY HEIMBERG | — |
| JOSEPH MCGOWAN | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Budget/Appropriations BUD
H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2014; provisions relating to FDA regulation and funding, sequestration, drug importation H.R. 2775, FY 14 Continuing Appropriations Act; provisions related to the implementation of the Budget Control Act of 2011: Public Law No. 112-25, funding for the Biomedical Advanced Research and Development Authority (BARDA)H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013; provisions related to FDA user fees S. 1284, Labor, Health and Human Services, Education and Related Agencies Appropriations Act of 2014; provisions related to ADAP, BARDA and Section 317
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY HEIMBERG | — |
| JOSEPH MCGOWAN | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.